Clinical Trial

A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)

Name: A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) — clinical trial record (NCT07261644)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study will evaluate the efficacy and safety of 608 in patients with AS.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-21.

Trial Details

NCT Number	NCT07261644
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Ankylosing Spondylitis
Enrollment	500 participants
Start Date	2025-11-07
Primary Completion	2027-01-14 (estimated)
Study Completion	2027-11-18 (estimated)
Updated on ClinicalTrials.gov	2025-12-10